BioAtla (BCAB) Net Shares Issued and Repurchased (2020 - 2026)

BioAtla (BCAB) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $9484.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased fell 72.44% year-over-year to $9484.0; the trailing twelve-month figure through Mar 2026 stood at $9484.0 (down 72.44% YoY), and the FY2025 full-year result was $253880.0, up 58.6% from the prior year.
• Net Shares Issued and Repurchased slipped to $9484.0 in Q1 2026 per BCAB's latest filing, from $253880.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $3.5 million in Q1 2023 and bottomed at $6000.0 in Q1 2024.
• Historically, Net Shares Issued and Repurchased has averaged $640242.0 across 5 years, with a median of $160072.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased soared 5250.0% in 2022, then slumped 99.83% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $50387.0 in 2022, then surged by 637.17% to $371439.0 in 2023, then tumbled by 56.9% to $160072.0 in 2024, then jumped by 58.6% to $253880.0 in 2025, then slumped by 96.26% to $9484.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $9484.0, $253880.0, and $34416.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.